Centiva Capital »

Eyepoint Pharmaceuticals shares owned by Centiva Capital

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Centiva Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.0M 272k 18.27

More positions owned by Centiva Capital

Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Put Option (TSLA)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alibaba Group Hldg Sponsored Ads Put Option (BABA)
Apple Call Option (AAPL)
Pdd Holdings Sponsored Ads Put Option (PDD)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Regeneron Pharmaceuticals Call Option (REGN)
Eli Lilly & Co. Put Option (LLY)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Honeywell International (HON)
Jd.com Spon Ads Cl A (JD)

View all positions for Centiva Capital

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
BlackRock
Federated Investors
Adage Capital Partners GP
Franklin Resources
Vanguard Group
Paradigm Biocapital Advisors
TCG Crossover Management
OrbiMed Advisors
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen
Goldman Sachs Group

View all funds holding Eyepoint Pharmaceuticals